Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1527-6473|24|3|380-393

ISSN: 1527-6465

Source: LIVER TRANSPLANTATION, Vol.24, Iss.3, 2018-03, pp. : 380-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract